About Bortezomib
Class: | Proteasome inhibitor
Use: | Treatment of multiple myeloma and certain types of lymphoma (specifically, relapsed or refractory multiple myeloma and mantle cell lymphoma)
Adult dose: | Initial dose of 1.3 mg/m² administered intravenously on days 1, 4, 8, and 11 of a 21-day cycle; may be adjusted based on tolerance and response
Pediatric dose: | Safety and efficacy not established; not recommended for use in pediatric patients
Side effects: | Common side effects include fatigue, pe
Drug Class
Proteasome inhibitor
Uses & Indications
Treatment of multiple myeloma and certain types of lymphoma (specifically, relapsed or refractory multiple myeloma and mantle cell lymphoma)
Storage Requirements
Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: EVER Valinject GmbH, AUSTRIA
Package Size
1 Glass Vial (1.4 ml)
Price & Supplier
Price in UAE: AED 2447.50
Dosage Information
Adult Dose
Initial dose of 1.3 mg/m² administered intravenously on days 1, 4, 8, and 11 of a 21-day cycle; may be adjusted based on tolerance and response
Pediatric Dose
Safety and efficacy not established; not recommended for use in pediatric patients
Side Effects
Common side effects include fatigue, peripheral neuropathy, nausea, diarrhea, constipation, thrombocytopenia, and anemia
Contraindications & Precautions
Hypersensitivity to bortezomib or any component of the formulation; caution in patients with severe hepatic impairment
Important Warnings
Risk of peripheral neuropathy, thrombocytopenia, and gastrointestinal perforation; monitor blood counts regularly; caution in patients with a history of herpes zoster infection due to increased risk of reactivation
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.